KARL-DIMITER BISSIG to Hepatitis B, Chronic
This is a "connection" page, showing publications KARL-DIMITER BISSIG has written about Hepatitis B, Chronic.
Connection Strength
0.376
-
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice. Cytotherapy. 2018 05; 20(5):697-705.
Score: 0.140
-
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides. J Hepatol. 2016 Apr; 64(4):781-9.
Score: 0.119
-
Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice. Sci Rep. 2015 Oct 20; 5:15259.
Score: 0.118